Avanos Medical Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thank you for joining us for today's session. My name is Sushil Bhandaru, and I'm an analyst in JPMorgan's Healthcare Investment Banking Group. And before we introduce you to our presenters today, we just want to call of note to the blue button at the bottom of the screen where you'll be able to submit any Q&A that you have during our session. With that, I'm pleased to introduce Joe Woody, CEO of Avanos; and Michael Greiner, SVP and CFO.
With that, I'll turn it over to them to talk to you a little bit about their story.
Thank you, Sushil. I'm very excited to update on Avanos, and I'm very -- thankful for those of you that are interested in the Avanos' story and our employees have been extremely resilient throughout the pandemic in setting the foundation really for our company going forward. As always, we'll be talking about forward-looking statements, risks like cost savings, reductions and raw material. The key is we'd like you to be able to be well aware of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |